[Federal Register Volume 90, Number 113 (Friday, June 13, 2025)]
[Notices]
[Page 25083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-10813]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on April 7, 2025, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC''), has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, AbViro LLC, Bethesda, MD; Advanced BioScience
Laboratories, Inc., Rockville, MD; Advanced Light Devices LLC, Las
Vegas, NV; AI Optics, Inc., New York, NY; Alamgir Research, Inc. dba
ARIScience, Wayland, MA; Alcamena Stem Cell Therapeutics LLC,
Halethorpe, MD; American Type Culture Collection, Manassas, VA;
BelleTorus Corp., Cambridge, MA; BIOPAC Systems, Inc., Goleta, CA;
Bitterroot Innovation LLC, Stevensville, MT; Business Enabled
Acquisition and Technology, Inc., San Antonio, TX; CereVu Medical,
Inc., San Francisco, CA; CleanBeam Technologies LLC, Greensboro, NC;
Clearview Limited LLC dba Grant Engine, Durham, NC; Clyra Medical
Technologies, Inc., Tampa, FL; Cornell University, Ithaca, NY;
CranioSense, Inc., Bedford, MA; DanForth Advisors, Waltham, MA; Dephy,
Inc., Boxborough, MA; Evrys Bio LLC, Doylestown, PA; Global Resonance
Technologies LLC, Shelbourne, VT; GreenLifeTech Corp., Banner Elk, NC;
Griffith University, Southport, COMMONWEALTH OF AUSTRALIA; Guide
Biomedical Solutions LLC, Media, PA; Healables Digital Health, Inc.,
Miami, FL; Health Helper Holdings, Inc., Hollywood, FL; Heartland GS
LLC, Delaware, OH; Hemerus Medical LLC, St Paul, MN; Humanetics Corp.,
Excelsior, MN; ICPupil, Ltd., Tel Aviv, STATE OF ISRAEL; Innovative
Design Labs, Inc., Minneapolis, MN; IntegerBio, Inc., Gaithersburg, MD;
KBR, Houston, TX; Layer 3 Services Pty, Ltd., Fyshwick, COMMONWEALTH OF
AUSTRALIA; LumenAstra, Inc., Boulder, CO; Matisse Pharmaceuticals,
B.V., Geleen, KINGDOM OF THE NETHERLANDS; Medasense Biometrics, Ltd.,
Ramat Gan, STATE OF ISRAEL; MendaCel, Inc., Laguna Beach, CA;
MHCombiotic, Inc., Calgary, CANADA; Miracus LLC, Troy, MI; Molecular
Technologies Laboratories dba InfinixBio, Galena, OH; Musculoskeletal
Transplant Foundation, Inc., Edison, NJ; Nanohmics, Inc., Austin, TX;
Neural Dynamics Technologies, Inc., Newton, MA; Neurovascular Research
and Design Corp., Tucson, AZ; NextCure, Inc., Beltsville, MD;
Nostopharma LLC, Bethesda, MD; Obvius Robotics, Inc., Sunrise, FL;
Orgenesis, Inc., Germantown, MD; pdx-tec LLC dba ppx-tec LLC, Jackson,
MS; Persistent Technology, Inc., Alexandria, VA; President and Fellows
of Harvard College, Cambridge, MA; PROYECCI[Oacute]N 22 SA DE CV,
Uruapan, UNITED MEXICAN STATES; Pulsethera, Inc., Chestnut Hill, MA;
Quest Consultants LLC dba Aerstone, Kensington, KINGDOM OF MOROCCO;
Radiatric, Inc., Washougal, WA; Results Group LLC, Glastonbury, CT;
Roam Robotics, Inc., San Francisco, CA; Safeguard Surgical, Tampa, FL;
SafePush LLC, New Orleans, LA; Sciperio, Inc., Orlando, FL; Senseye,
Inc., Austin, TX; SereNeuro Therapeutics, Inc., Baltimore, MD;
Signature Performance, Inc., Omaha, NE; SilverStream Medical, Caesarea,
STATE OF ISRAEL; Solascure, Ltd., Cambridge, UNITED KINGDOM; Stoic Bio,
Inc., San Diego, CA; Summit Technology Laboratory, Irvine, CA;
Tillerline Associates LLC, Solon, OH; Tunnell Consulting, Inc.,
Bethesda, MD; University of Arkansas for Medical Sciences, Little Rock,
AR; Valinor Enterprises, Alexandria, VA; Vira Regen, Inc., Salt Lake
City, UT; and VitaKey, Inc., Birmingham, AL have been added as parties
to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on January 6,
2025. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on February 4, 2025 (90 FR 8943).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-10813 Filed 6-12-25; 8:45 am]
BILLING CODE P